PPARG and hepatocellular carcinoma: Moreover, our observations indicate that PPARγ agonist-induced ROS generation enhanced AKT phosphorylation, which significantly impaired the inhibitory effect of PPARγ agonists on cell proliferation and the stem cell-like phenotype of HCC cells.